Coronavirus Disease-2019 Infection in Neonates of an Infected Pregnant Mother with Triplets

Authors

  • Lida Ahmadi Newborn Expert in Vise Chancellor for Treatment, Tehran University of Medical Sciences, Tehran, Iran
  • Mandana Bassirnia Department of Pediatrics, Tehran University of Medical Sciences, Arash Hospital, Tehran, Iran
  • Mohammadreza Shiva Department of Pediatric Nephrology, Tehran University of Medical Sciences, Arash Hospital, Tehran, Iran
  • Nima Taheri Derakhsh Department of Intensive Care Medicine, Tehran University of Medical Sciences, Arash Hospital, Tehran, Iran
  • Sedigheh Yousefzadegan Department of Pediatric Pulmonary Diseases, Iran University of Medical Sciences, Firoozabadi Hospital, Tehran, Iran
  • Zohreh Farsi Department of Neonatology, Tehran University of Medical Sciences, Arash Hospital, Tehran, Iran
Abstract:

Background: Coronavirus disease 2019 (COVID-19) infection is continuing its spread across the world with nearly 13 million people involvement by 11 July 2020. It mainly causes respiratory infection and affects different people in different ways. The COVID-19 infection involves many pregnant women worldwide, and maternal-fetal transmission of viral diseases is a major concern about this virus. However, its vertical transmission has to be proven in further studies.Case report: This study presents a COVID-19-infected woman pregnant with triplets that underwent urgent cesarean section in a tertiary center of gynecology and neonatology. Subsequently, neonatal outcomes will be investigated in this study. All neonates were born with low Apgar scores and transferred to the neonatal intensive care unit (NICU) immediately after birth. Polymerase chain reaction (PCR) test of the second male neonate was positive on days 3 and 6; however, he was finally discharged from the hospital in a good condition. It is worth mentioning that the other two newborns died. All three neonates had white lung with an unfavorable response to treatment.Conclusion: In this case study, we explain and discuss the probable COVID-19 infection in another two offsprings, elaborate on the mother's risk factors predisposing her to get involved with COVID-19 infection, and recommend some suggestions to avoid such complications.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Hematology findings in patients with Coronavirus disease 2019 (COVID-19)

In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...

full text

Clinical Case Series of Gastrointestinal Symptoms in Patients with Novel Coronavirus 2019 (COVID-19) Infection

IMPORTANCE: Since the outbreak of coronavirus disease 2019 (COVID-19), various digestive symptoms have been frequently reported in a significant portion of patients infected with the virus. It is well established that most patients with COVID-19 have fever along with respiratory signs and symptoms, such as cough and dyspnea. We present 36 cases with chief complaint of gastrointestinal (GI) symp...

full text

Neonates from mother with autoimmune disease

expression of disease; rather they have only one or two organ systems involved. To date, complete CHB is irreversible. In contrast, the noncardiac manifestations are transient, resolving at about six months of life coincident with the disappearance of maternal autoantibodies from the neonatal circulation. Neonatal autoimmune thrombocytopenia Immune thrombocytopenic purpura (ITP) accounts for ab...

full text

Obesity and Coronavirus Disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection that was first reported on December 31, 2019 in China . This disease behaves variously: from asymptomatic infection to influenza-like symptoms and severe acute respiratory distress syndrome (ARDS) . In the recent months, COVID-19 has infected millions and killed hundre...

full text

A Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)

The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...

full text

A Review of Coronavirus Disease-2019 (COVID-19)

There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, China in December 2019. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 11  issue 3

pages  120- 122

publication date 2020-08-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023